CHE · Chemed Corp · Executive Compensation
$546.85
+0.13 (+0.02%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$7.12B
Shares
13.01M
Volume · Nov 19
24.83K
Avg daily vol (3M)
151.72K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Nicholas M. Westfall | Chairman and Chief Executive Officer of Vitas | Resigned | 2025-07-29 |
| David P. Williams | Executive Vice President and Chief Financial Officer | Resigned | 2024-02-01 |
| Michael D. Witzeman | Chief Financial Officer | Appointed | 2023-12-18 |
| David P. Williams | Executive Vice President and Chief Financial Officer | Retired | 2023-11-03 |
| Donald E. Saunders | Board of Directors | Retired | 2022-08-05 |
Leadership
Key facts
CIK
19584
CUSIP
16359R103
13F (30d)
559 filings
500 filers
Visit website
Investor relations